Status:
NOT_YET_RECRUITING
Clinical Evaluation of the Scopio Cell Morphology Technology
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Blood Cancer
Eligibility:
All Genders
18-80 years
Brief Summary
Digital morphology is currently expanding and developing new applications based on artificial intelligence software. We recently published a study comparing screen validation and microscopic reading o...
Eligibility Criteria
Inclusion
- Patients suffering from hemopathies with bone marrow aspirate assessable under the optical microscope
Exclusion
- Patients not affected by blood disorders
- Patients suffering from hemopathies with bone marrow aspirate that cannot be assessed under the optical microscope
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06574308
Start Date
September 1 2024
End Date
September 1 2025
Last Update
August 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, Italy, 00168